Canopy Growth ROA 2018-2017 | CGC

Current and historical return on assets (ROA) values for Canopy Growth (CGC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Canopy Growth ROA for the three months ending December 31, 2017 was -13.74%.
Canopy Growth Annual ROA
2017 -2.46
2016 0.00
Canopy Growth Quarterly ROA
Q3 2017 1.01
Q2 2017 -0.20
Q1 2017 -0.60
Q4 2017 -3.09
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $11.858B $0.061B
Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $130.838B 20.06
Abbott Laboratories (ABT) United States $120.013B 25.15
Stryker (SYK) United States $65.112B 25.16
Boston Scientific (BSX) United States $52.026B 27.07
Baxter (BAX) United States $41.267B 28.09
Zimmer Biomet Holdings (ZBH) United States $26.545B 17.05
Smith & Nephew SNATS (SNN) United Kingdom $16.410B 0.00
ResMed (RMD) United States $16.185B 32.13
Perrigo (PRGO) Ireland $9.987B 14.17
Bio-Rad Laboratories (BIO) United States $8.907B 57.19
Insulet (PODD) United States $6.172B 0.00
Hill-Rom Holdings (HRC) United States $6.169B 20.92
Haemonetics (HAE) United States $5.675B 51.78
ICU Medical (ICUI) United States $5.526B 37.45
Neogen (NEOG) United States $4.833B 76.90
Agios Pharmaceuticals (AGIO) United States $4.156B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.143B 0.00
Hutchison China MediTech (HCM) China $3.756B 0.00
NuVasive (NUVA) United States $3.623B 34.37
National Vision Holdings (EYE) United States $3.287B 72.58
Quidel (QDEL) United States $2.826B 57.89
NxStage Medical (NXTM) United States $1.862B 0.00
Phibro Animal Health (PAHC) United States $1.766B 25.14
Cardiovascular Systems (CSII) United States $1.275B 761.20
AtriCure (ATRC) United States $1.215B 0.00
Omeros (OMER) United States $1.211B 0.00
VAREX IMAGING (VREX) United States $1.146B 18.73
PetIQ (PETQ) United States $1.073B 35.10
Owens & Minor (OMI) United States $1.064B 11.38
Surmodics (SRDX) United States $1.055B 127.42
Eagle Pharmaceuticals (EGRX) United States $1.021B 30.15
MacroGenics (MGNX) United States $0.991B 0.00
Cerus (CERS) United States $0.970B 0.00
OraSure Technologies (OSUR) United States $0.946B 61.88
TG Therapeutics (TGTX) United States $0.750B 0.00
Insys Therapeutics (INSY) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.671B 32.16
Meridian Bioscience (VIVO) United States $0.649B 22.17
Lantheus Holdings (LNTH) United States $0.619B 19.23
Evolus (EOLS) United States $0.503B 0.00
NanoString Technologies (NSTG) United States $0.503B 0.00
Cytosorbents (CTSO) United States $0.411B 0.00
Quanterix (QTRX) United States $0.410B 0.00
Utah Medical Products (UTMD) United States $0.377B 24.25
BioLife Solutions (BLFS) United States $0.295B 0.00
Surface Oncology (SURF) United States $0.290B 0.00
Bovie Medical (BVX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.216B 0.00
Chimerix (CMRX) United States $0.182B 0.00
Fonar (FONR) United States $0.156B 7.79
Conatus Pharmaceuticals (CNAT) United States $0.142B 0.00
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Female Health (VERU) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.083B 0.00
Trinity Biotech (TRIB) Ireland $0.081B 24.13
United-Guardian (UG) United States $0.077B 17.02
Neurotrope (NTRP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.063B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Capricor Therapeutics (CAPR) United States $0.035B 0.00
Myomo (MYO) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Akers Biosciences Inc (AKER) United States $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00